Mitchell E. Taub
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 35
- Drug Transport and Resistance Mechanisms 33
- Co-authors
- Lalitha Podila (4 shared papers)Sven Frøkjær (7 shared papers)Maciej J. Zamek‐Gliszczynski (4 shared papers)Thomas Ebner (4 shared papers)Rucha Sane (4 shared papers)Harma Ellens (4 shared papers)Bente Steffansen (6 shared papers)Naoki Ishiguro (2 shared papers)
- Journals
- Drug Metabolism and Disposition (14 papers)Pharmaceutical Research (5 papers)Journal of Pharmaceutical Sciences (4 papers)International Journal of Pharmaceutics (3 papers)European Journal of Pharmaceutical Sciences (3 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Mitchell E. Taub
51 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 89
- Pharmacology 388
- Oncology 918
- Pediatrics, Perinatology and Child Health 446
- Pharmaceutical Science 111
- Biochemistry 94
Countries citing papers authored by Mitchell E. Taub
This map shows the geographic impact of Mitchell E. Taub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell E. Taub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell E. Taub more than expected).
Fields of papers citing papers by Mitchell E. Taub
This network shows the impact of papers produced by Mitchell E. Taub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell E. Taub. The network helps show where Mitchell E. Taub may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell E. Taub, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 171 | |
| 2 | 2013 | 160 | |
| 3 | 2015 | 117 | |
| 4 | 2005 | 108 | |
| 5 | 2012 | 66 | |
| 6 | 2011 | 61 | |
| 7 | 2013 | 60 | |
| 8 | 2015 | 60 | |
| 9 | 2001 | 60 | |
| 10 | 2002 | 59 | |
| 11 | 1992 | 56 | |
| 12 | 2020 | 45 | |
| 13 | 2018 | 41 | |
| 14 | 2014 | 32 | |
| 15 | 2017 | 28 | |
| 16 | 2014 | 26 | |
| 17 | 2013 | 25 | |
| 18 | 2020 | 24 | |
| 19 | 2011 | 23 | |
| 20 | 1999 | 17 |
About Mitchell E. Taub
Mitchell E. Taub is a scholar working on Oncology, Molecular Biology, Pharmacology, Pediatrics, Perinatology and Child Health and Biochemistry, having authored 58 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (33 papers), Pharmacogenetics and Drug Metabolism (13 papers), Pharmacological Effects and Toxicity Studies (10 papers), Amino Acid Enzymes and Metabolism (9 papers), HIV/AIDS drug development and treatment (5 papers), Metabolism and Genetic Disorders (4 papers), Drug Solubulity and Delivery Systems (3 papers) and Gastroesophageal reflux and treatments (3 papers). The work is most often cited by research in Pharmacology (388 citations), Oncology (918 citations), Pediatrics, Perinatology and Child Health (446 citations), Pharmaceutical Science (111 citations) and Biochemistry (94 citations). Mitchell E. Taub has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Lalitha Podila, Sven Frøkjær, Maciej J. Zamek‐Gliszczynski, Thomas Ebner, Rucha Sane, Harma Ellens, Bente Steffansen, Naoki Ishiguro, Xiaoyan Chu and Donald Tweedie. Their work appears in journals such as Drug Metabolism and Disposition, Pharmaceutical Research, Journal of Pharmaceutical Sciences, International Journal of Pharmaceutics and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.